Celltrion Healthcare’s ‘Truxima’ expanded to 18 European countries only in 1 year

Celltrion Healthcare is quickly extending the rage of its European distribution network for ‘Truxima(generic name: rituximab),’ an antibody biosimilar for hematologic malignancies.

According to Celltrion Healthcare, they launched ‘Truxima’ in the U.K. for the first time Europe, completed the launch in 5 major countries including Germany, France, Spain and Italy, and expanded its distribution c...